Page last updated: 2024-11-13

4,4-difluoro-4-bora-3a,4a-diaza-s-indacene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID25058173
CHEMBL ID3343406
CHEBI ID51107
SCHEMBL ID1058513
MeSH IDM0251441

Synonyms (11)

Synonym
CHEBI:51107 ,
difluoro{2-[(2h-pyrrol-2-ylidene-kappan)methyl]-1h-pyrrolato-kappan}boron
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
bodipy
138026-71-8
SCHEMBL1058513
CHEMBL3343406
dipyrrometheneboron difluoride
Q27122411
GUHHEAYOTAJBPT-UHFFFAOYSA-N
2,2-difluoro-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaene

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The toxic lipid effects include inflammation and under sustained exposure apoptosis."( Toxicity of oxidized phosphatidylcholines in cultured human melanoma cells.
Hermetter, A; Hofmann-Wellenhof, R; Jaritz, H; Köfeler, H; Ramprecht, C; Schaider, H; Streith, I; Zenzmaier, E, 2015
)
0.42

Compound-Compound Interactions

ExcerptReferenceRelevance
" In addition, cells were incubated with mitoxantrone in the absence and presence of increasing concentrations of different compounds with the potential to interact with BCRP."( A fluorescence-based in vitro assay for drug interactions with breast cancer resistance protein (BCRP, ABCG2).
Delzer, J; Fricker, G; Mahringer, A, 2009
)
0.35
" BODIPY-ATP can interact with Tween 20-AuNPs through the coordination between the adenine group of BODIPY-ATP and Au atoms on the NP surface, thereby causing the fluorescence quenching of BODIPY-ATP through the nanometal surface energy transfer (NSET) effect."( Tween 20-stabilized gold nanoparticles combined with adenosine triphosphate-BODIPY conjugates for the fluorescence detection of adenosine with more than 1000-fold selectivity.
Hung, SY; Shih, YC; Tseng, WL, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" Knowledge of MT aggregation in aqueous solutions and of its interaction with lipid membranes is important to understand pharmacokinetics, bioavailability and antiparasitic effects."( Miltefosine and BODIPY-labeled alkylphosphocholine with leishmanicidal activity: Aggregation properties and interaction with model membranes.
Acuña, AU; Barioni, MB; Ito, AS; Ramos, AP; Zaniquelli, ME, 2015
)
0.42
" We also examined an approach to improve intestinal absorption of a poorly absorbed water-insoluble component, coenzyme Q10 (CoQ10), by this mechanism."( An Approach to Improve Intestinal Absorption of Poorly Absorbed Water-Insoluble Components via Niemann-Pick C1-Like 1.
Imai, M; Iseki, K; Noto, K; Sato, Y; Sugawara, M; Sumi, M; Takekawa, Y; Takekuma, Y; Yamaki, Y, 2016
)
0.43
" Our work demonstrated that conjugation of BODIPYs with HSA may be a promising strategy to enhance the performance of BODIPY-based PSs, and the combination of computational and experimental techniques is expected to play key roles in the design and development of novel PSs with improved bioavailability and biocompatibility for cancer therapeutic applications."( Insights into the binding mechanism of BODIPY-based photosensitizers to human serum albumin: A combined experimental and computational study.
Chen, Y; Fu, G; Huang, M; Jiang, L; Li, J; Liu, J; Liu, JY; Liu, L; Liu, Y; Song, M; Xue, J, 2018
)
0.48
" However, typical Bodipys are highly lipophilic, which often results in nonfluorescent aggregates in aqueous solution and also severely limits their bioavailability to cells and tissues."( Carbon-Dipyrromethenes: Bright Cationic Fluorescent Dyes and Potential Application in Revealing Cellular Trafficking of Mitochondrial Glutathione Conjugates.
Guo, W; Liu, J; Liu, M; Sun, YQ; Zhang, H, 2020
)
0.56
" However, o-carborane is a fat-soluble compound, its hydrophobicity is too strong, and its bioavailability is poor."( Water-soluble BODIPY-nido-carborane nanoparticles applied to biocompatibility tumor cell imaging.
Dai, D; Feng, J; He, X; Jin, G; Lian, G, 2022
)
0.72
" The druglikeness and pharmacokinetic properties of C4 are evaluated using the SwissADME and its bioavailability and toxicity profiles are assessed using the SwissADME, preADMET and pkCSM servers."( Exploring anticancer properties of novel Nano-Formulation of BODIPY Compound, Photophysicochemical, in vitro and in silico evaluations.
Budama-Kilinc, Y; Erdoğmuş, A; Gok, B; Karanlık, CC; Karanlık, G; Kecel-Gunduz, S, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" Dose-response relations for the nAChR beta19'Lys(BODIPYFL) receptors were similar to those for wild-type receptors."( Single-molecule imaging of a fluorescent unnatural amino acid incorporated into nicotinic receptors.
Dibas, MI; Dougherty, DA; Lester, HA; Pantoja, R; Rodriguez, EA, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
BODIPY compoundA compound that contains a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID1163010Cytotoxicity against human U2OS cells after 72 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163014Cytotoxicity against human MIAPaCa2 cells after 24 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1162999Cytotoxicity against human LNCAP cells after 24 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163000Cytotoxicity against human LNCAP cells after 48 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163002Cytotoxicity against human PC3 cells after 24 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163007Cytotoxicity against mouse C2C12 cells after 72 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163011Cytotoxicity against human MCF7 cells after 24 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163018Cytotoxicity against human HT-29 cells after 48 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163005Cytotoxicity against mouse C2C12 cells after 24 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163006Cytotoxicity against mouse C2C12 cells after 48 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163019Cytotoxicity against human HT-29 cells after 72 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163008Cytotoxicity against human U2OS cells after 24 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163027Induction of LPS-induced NO production in rat peritoneal cells after 24 hrs using DAR-2 probe by fluorescence assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163017Cytotoxicity against human HT-29 cells after 24 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163013Cytotoxicity against human MCF7 cells after 72 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163012Cytotoxicity against human MCF7 cells after 48 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163015Cytotoxicity against human MIAPaCa2 cells after 48 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163009Cytotoxicity against human U2OS cells after 48 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163029Induction of TNFalpha production in rat peritoneal cells at 0.01 to 40 uM after 24 hrs by ELISA2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163004Cytotoxicity against human PC3 cells after 72 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163003Cytotoxicity against human PC3 cells after 48 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163016Cytotoxicity against human MIAPaCa2 cells after 72 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
AID1163001Cytotoxicity against human LNCAP cells after 72 hrs by WST-1 assay2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Tailor-made fluorescent trilobolide to study its biological relevance.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,902)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's98 (5.15)18.2507
2000's392 (20.61)29.6817
2010's989 (52.00)24.3611
2020's423 (22.24)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.87 (24.57)
Research Supply Index7.57 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.05%)5.53%
Reviews55 (2.85%)6.00%
Case Studies1 (0.05%)4.05%
Observational0 (0.00%)0.25%
Other1,871 (97.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]